Abstract
Riociguat is a soluble guanylate cyclase stimulator used for pulmonary hypertension (PH) treatment. We evaluated right ventricular (RV) contractile function in 27 PH patients receiving riociguat. A comparison of pre- and post-administration echocardiographic studies demonstrated significantly improved RV strain after riociguat treatment, even after adjusting for RV afterload.
Original language | English |
---|---|
Journal | Pulmonary Circulation |
Volume | 8 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2018 Jan 1 |
Keywords
- Pulmonary hypertension
- Right ventricular contraction
- Riociguat
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine